May 05, 2020 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the 2020 Stockholders' Annual Meeting of Neoleukin Therapeutics. (Operator Instructions)
I would now like to hand the conference over to your speaker, Mr. Bob Ho. Please go ahead.
Robert Ho - Neoleukin Therapeutics, Inc. - CFO & Secretary
Thanks, Amanda. Good afternoon. I am Bob Ho, Secretary and Chief Financial Officer of Neoleukin Therapeutics, Inc., which we will refer to as Neoleukin and what follows. Welcome to our 2020 annual meeting. I would like to introduce Dr. Jonathan Drachman, our Chief Executive Officer, President and Member of the Board of Directors, who will call the meeting to order. Jonathan?
Jonathan G. Drachman - Neoleukin Therapeutics, Inc. - CEO, President & Director
Thanks, Bob. Good afternoon. My name is Jonathan Drachman. I am the Chief Executive Officer, President and the Director of Neoleukin. I now call the meeting to order.
With us here today are the following members of our Board of Directors: Dr.
Neoleukin Therapeutics Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
